Trial · NCT07879534
Injectable Platelet-Rich Fibrin Versus Hyaluronic Acid for Thin Gingival Phenotype
NCT07879534, Not applicable, Completed, University of Yaounde 1
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Injectable Platelet-Rich Fibrin Versus Hyaluronic Acid for Thin Gingival Phenotype. Trials, record NCT07879534. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07879534
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Injectable Platelet-Rich Fibrin Versus Hyaluronic Acid for Thin Gingival Phenotype
- NCT number
- NCT07879534
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 11 participants, actual
- Lead sponsor
- University of Yaounde 1
- Conditions
- Thin Gingival Phenotype
- Interventions
- Injectable Platelet Rich Fibrin, Hyaluronic Acid
- First posted
- 2026-10-19
- Last updated
- 2026-10-19
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Gingival Thickness (GT) | Baseline; 30 days after the third injection; 2 months after the first follow-up | Gingival thickness measured in millimeters by standardized transgingival probing and digital caliper. |
| Primary | Keratinized Tissue Width (KTW) | Baseline; 30 days after the third injection; 2 months after the first follow-up | Keratinized tissue width measured in millimeters from the free gingival margin to the mucogingival junction. |
| Secondary | Gingival Inflammation | Baseline; 30 days after the third injection; 2 months after the first follow-up | Gingival inflammation assessed using a 0 to 3 ordinal gingival index. |
| Secondary | Bleeding on Probing | Baseline; 30 days after the third injection; 2 months after the first follow-up | Bleeding on probing assessed using the study 0 to 5 ordinal bleeding severity scale. |
| Secondary | Probing Depth Category | Baseline; 30 days after the third injection; 2 months after the first follow-up | Probing depth recorded as an ordinal category: less than 3 mm, 3 to 5 mm, or greater than 5 mm. |
| Secondary | Injection-Related Pain | Day 0; Day 7; Day 14 | Pain assessed on a four-grade verbal scale: absent, mild, moderate, or severe. |
| Secondary | Injection-Related Edema | Day 0; Day 7; Day 14 | Edema assessed on a four-grade verbal scale: absent, mild, moderate, or severe. |
| Secondary | Postoperative Bleeding | Day 0; Day 7; Day 14 | Postoperative bleeding assessed on a four-grade verbal scale: absent, mild, moderate, or severe. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07879534
GET https://conductscience.org/api/trials/v1/NCT07879534/registered